MedTrace Logo

Viability of Pulsioflex Monitoring in ICU

NCT04911985 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 42

Last updated 2021-06-08

No results posted yet for this study

Summary

Goal of the Study is to Study the precision of semi-invasive cardiac index monitoring by means of the ProAQT (PULSION Medical Systems SE) sensor, whereby the pulmonary artery catheter will serve as gold standard.

Conditions

  • Cardiogenic Shock

Interventions

DEVICE

Measurement of the Cardiac Output/ Cardiac Index

Semiinvasive Measurement of the Cardiac Output/ Cardiac Index with the Pulsion device

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-01
Primary Completion
2019-02-01
Completion
2019-08-30
FDA Device
Yes

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04911985 on ClinicalTrials.gov